Category: Editorial

Attaching importance to the genetic diagnosis of early-onset high myopia

2022, No. 03, Editorial

Author: Sheng Xunlun DOI: 10.3760/cma.j.cn115989-20210915-00517 Published 2022-03-10 Cite asChin J Exp Ophthalmol, 2022, 40(3): 193-198. Abstract                               [View PDF] [Read Full Text] According to the onset age, high myopia can be divided into late-onset high myopia (loHM) and early-onset high myopia (eoHM). Numerous genetic studies have […]

The opportunities of metabolic windows for early diagnosis and precise prevention and treatment of diabetic retinopathy

2022, No. 01, Editorial

Authors: Zhang Fang,  Xu Xun DOI: 10.3760/cma.j.cn115989-20211209-00678 Published 2022-01-10 Cite asChin J Exp Ophthalmol, 2022, 40(1): 1-5. Abstract                              [View PDF]  [Read Full Text] Diabetes mellitus (DM) is a chronic metabolic disease caused by multiple etiologies. Diabetic retinopathy (DR), as a primary ocular […]

Future developments and trends in refractive surgery

2021, No. 12, Editorial

Authors: Wang Yan,  Ma Jiaonan DOI: 10.3760/cma.j.cn115989-20210804-00446 Published 2021-12-10 Cite asChin J Exp Ophthalmol, 2021, 39(12): 1025-1030. Abstract                              [View PDF] [Read Full Text] Refractive surgery is one of the important methods for refractive error correction, which include corneal refractive surgery and intraocular refractive surgery.In recent […]

Pay attention to the risk of infection and tumor progression during application of TNF-α inhibitors in uveitis

2021, No. 11, Editorial

Authors: Chi Ying,  Yang Liu DOI: 10.3760/cma.j.cn115989-20211020-00571 Published 2021-11-10 Cite asChin J Exp Ophthalmol, 2021, 39(11): 929-932. Abstract                              [View PDF] [Read Full Text] Adalimumab, one of the tumor necrosis factor-α (TNF-α) inhibitors, has been approved as a therapeutic drug for non-infectious intermediate, posterior and pan-uveitis […]

Paying attention to the natural course of disease for a development of gene therapy of inherited retinal diseases

2021, No. 08, Editorial

Authors: Wang Fenghua,  Chen Jieqiong,  Sun Xiaodong DOI: 10.3760/cma.j.cn115989-20201007-00677 Published 2021-08-10 Cite asChin J Exp Ophthalmol, 2021, 39(8): 665-669. Abstract                              [View PDF] [Read Full Text] Most inherited retinal diseases (IRDs) severely impair vision and lack effective treatments.With the approval of Luxturna, the world’s first gene […]

Exploring age-related visual dysfunctions and strategies for visual function restoration

2021, No. 08, Editorial

Authors: Lyu Fan,  Li Jin,  Pan Anpeng DOI: 10.3760/cma.j.cn115989-20210401-00224 Published 2021-08-10 Cite asChin J Exp Ophthalmol, 2021, 39(8): 670-675. Abstract                              [View PDF] [Read Full Text] According to the international definition on the aging society, China has entered an aging population period.The research and strategies addressed […]

Multiple fundus imaging diagnosis: knowing the principles well for a rational application

2021, No. 05, Editorial

Authors: Wen Feng,  Hua Rui DOI: 10.3760/cma.j.cn115989-20210302-00140 Published 2021-05-10 Cite asChin J Exp Ophthalmol, 2021, 39(5): 376-381. Abstract                              [View PDF] [Read Full Text]  Multimodal fundus imaging techniques, based on lights and shadows, appear to have a rapidly great progress in recent years.Fundus […]

Paying close attention to the impact of cataract phacoemulsification surgery on ocular tissue

2021, No. 04, Editorial

Author: Guan Huaijin DOI: 10.3760/cma.j.cn115989-20200424-00283 Published 2021-04-10 Cite asChin J Exp Ophthalmol, 2021, 39(4): 273-279. Abstract                             [View PDF]   [Read Full Text]  Although phacoemulsification is quite minimally invasive, effective and safe, it can still injure the structure of eyes and cause and/or aggravate […]